Relax it will come. This is only the beginning. We will see $2 in June some time. Everyone is skeptical since it failed the trial. This news is great but lets see how Celsion moves forward with the FDA. GLTA Longs!!!!!
I predict that the FDA will be very lenient with Celsion because:
1. Thermodox is a drug the chineese need (which makes approval important for international political reasons)
2. Celsion worked very closely and was extremely cooperative with FDA for the entire process. Many companies cut corners or walk a thin line with the FDA - cession did the opposite.
3. The HEAT study is the single most informative clinical trial concerning RFA - the data generated by heat is VERY important to the whole oncology community - what Im trying to say is that Celsion has earned a few favors from HEAT